A detailed history of Hollencrest Capital Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Hollencrest Capital Management holds 1,328 shares of BSX stock, worth $134,977. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,328
Previous 1,181 12.45%
Holding current value
$134,977
Previous $90,000 23.33%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$72.96 - $84.0 $10,725 - $12,348
147 Added 12.45%
1,328 $111,000
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $33,415 - $39,715
687 Added 139.07%
1,181 $68,000
Q4 2022

Feb 06, 2023

BUY
$39.56 - $47.22 $19,542 - $23,326
494 New
494 $22,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.